about
Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine careUtility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial.The distribution of COPD in UK general practice using the new GOLD classification.GOLD guidelines 2011: what are the implications for primary care?A woman with breathlessness: a practical approach to diagnosis and management.Novel study design to assess the utility of the copd assessment test in a primary care setting.Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study.The Primary Care Respiratory Society-UK Quality Award: development and piloting of quality standards for primary care respiratory medicine.What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)?The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?Summary of the consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England.Implementing the change in National Institute for Health and Clinical Excellence guidance on airflow obstruction grading in chronic obstructive pulmonary disease.The use of exhaled nitric oxide monitoring in primary care asthma clinics: a pilot studyActivity levels after pulmonary rehabilitation – what really happens?Assessing asthma control in routine clinical practice: use of the Royal College of Physicians ‘3 Questions’What standards and terms of employment should respiratory practitioners with a special interest expect from an employing organisation?A national strategy for the management of chronic obstructive pulmonary disease (COPD) in England: aiming to improve the quality of care for patientsConflicting standards for diagnostic spirometry within-session repeatability are confusingClinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patientsWorking for Better Asthma Control: How Can We Improve the Dialogue Between Patients and Healthcare Professionals?
P50
Q37304921-A5DC21C2-FDC9-4162-897A-EDCCFF368105Q38071176-A7A142AE-F302-40EF-8D78-CDE4448187FBQ39323164-67537D92-1352-4A55-A32A-56223D67A783Q39587692-2456D20F-AAD4-45C8-9101-297D9893C066Q42253419-ABF41F9C-5BF2-4CB6-BCEE-7BA2ECC7F58CQ43146703-25A08F51-AC95-497F-85F9-8D54F05CC065Q45913596-590C907E-42A3-42BB-A625-C7B1E2A10CF1Q48182104-1D6340C9-FA56-4AB1-9941-F4E7923B17FDQ50880837-F77341F7-8199-4652-8C8A-003EF66DA224Q51045849-8E01D359-4A0E-4C5B-AF91-AAA592B13D7BQ51630020-783C2F59-6677-4AF7-8BB0-3EF04DE1ABDBQ51748220-4F1C1F93-6231-47D3-BCB3-6E60A9C4BD8BQ56785686-83093254-AC11-4AA2-B46D-2ED31FBC87C5Q57940579-F533E506-787E-4AAA-AEB8-C1FAB1D299A3Q60713928-9D055DF1-8A6C-4EE3-B2CD-8F46AFDCA9AFQ80387591-2E840CAB-4BBA-4AD1-8A51-CEAB406B18BBQ83174194-348D4D6F-4FC5-43CD-A630-79E96FE301B0Q84205016-D35BEEA7-DCD8-41D5-8C85-3C988DBCCA93Q86639478-5FC061F2-BAFE-4D35-B6D7-B574A2697024Q91003183-56913CC4-75E3-482B-AA4E-A4281D485A82
P50
description
researcher ORCID ID = 0000-0002-4651-5961
@en
name
Kevin Gruffydd-Jones
@ast
Kevin Gruffydd-Jones
@en
Kevin Gruffydd-Jones
@es
Kevin Gruffydd-Jones
@nl
type
label
Kevin Gruffydd-Jones
@ast
Kevin Gruffydd-Jones
@en
Kevin Gruffydd-Jones
@es
Kevin Gruffydd-Jones
@nl
prefLabel
Kevin Gruffydd-Jones
@ast
Kevin Gruffydd-Jones
@en
Kevin Gruffydd-Jones
@es
Kevin Gruffydd-Jones
@nl
P31
P496
0000-0002-4651-5961